3 completed, 2 recruiting. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Recruiting 2 |
| Phase 3 | 1 | Completed 1 |
Follow Kevin Winthrop: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epetraborole in Patients With Mycobacterium Abscessus Lung Disease Epetraborole, Placebo - Mycobacterium Abscessus Infection | Phase 2 | Recruiting | Kevin Winthrop | 84 | 2026-03-30 | 2026-05-06 |
| Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin ORC-13661, Placebo - Ototoxicity, Drug-Induced | Phase 2 | Recruiting | Kevin Winthrop | 105 | 2025-06-02 | 2026-10-01 |
| Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease Azithromycin, Ethambutol, Rifampin - Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection | Phase 2 / Phase 3 | Completed | Kevin Winthrop | 474 | 2019-02-22 | 2026-02-02 |
| Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease LAI plus multi-drug regimen - Mycobacterium Infections, Nontuberculous, Mycobacteria, Atypical | Phase 2 | Completed | Kevin Winthrop | 30 | 2016-10-01 | 2020-03-04 |
| The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept Varicella Zoster Vaccine, Placebo Injection - Herpes Zoster, Inflammatory Disease | Phase 2 | Completed | Kevin Winthrop | 154 | 2014-05-08 | 2026-05-06 |
Mycobacterium Infections, Nontuberculous (3) · Mycobacterium Infections (2) · Arthritis, Rheumatoid (1) · Hearing Loss (1) · Herpes Zoster (1) · Mycobacterium avium-intracellulare Infection (1) · Ototoxicity (1) · Respiratory Aspiration (1)
Azithromycin (1) · Ethambutol (1) · Herpes Zoster Vaccine (1) · ORC-13661 (1) · Rifampin (1)
United States (5) · Canada (1)
Kevin L Winthrop, MD, MPH (4) · Edwin Rubel, PhD (1) · Emily Henkle, PhD, MPH (1)
U01DC020175 (1)